| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $14K | -70.4% |
| Cost of Revenue | $3K | -72.5% |
| Gross Profit | $11K | -69.6% |
| R&D Expense | $9K | +0.0% |
| SG&A Expense | $414K | +4.8% |
| Operating Income | -$404K | -9.6% |
| Net Income | -$409K | -11.1% |
| EPS (Basic) | -$0.01 | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6K | +0.0% |
| Inventory | $14K | +0.0% |
| Current Assets | $1K | -94.6% |
| Total Assets | $4K | -85.1% |
| Current Liabilities | $444K | +156.3% |
| Total Liabilities | $444K | +156.3% |
| Stockholders' Equity | -$440K | -195.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Financing Cash Flow | $55K | +32.4% |